News Release

Association of Pfizer-BioNTech COVID-19 vaccination during pregnancy with infant outcomes

JAMA Pediatrics

Peer-Reviewed Publication

JAMA Network

What The Study Did: This large population-based study found no evident differences between newborns of women who received the Pfizer-BioNTech COVID-19 vaccine (BNT162b2 messenger RNA) during pregnancy compared with those newborns of women who weren't vaccinated. Interpretation of study findings is limited by the observational design of the study.

Authors: Inbal Goldshtein, Ph.D., of Maccabi Healthcare Services in Tel Aviv, Israel, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.